Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-5.99
↓ 257% vs avg
Percentile
P21
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
3.83
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -5.99 | -53.5% |
| 2024 | -3.90 | -29.8% |
| 2023 | -3.01 | +65.9% |
| 2022 | -8.82 | +16.1% |
| 2021 | -10.51 | +52.2% |
| 2020 | -21.98 | -178.1% |
| 2019 | 28.14 | +52.8% |
| 2018 | 18.42 | -40.4% |
| 2017 | 30.92 | +106.1% |
| 2016 | 15.00 | - |